ERBB2 and breast carcinoma: The scientists also tested this system in ErbB2 overexpressing SKBR3 breast cancer cells, where magnetic contrast agent and SPIONs, tagged with anti-ErbB2, were released rapidly due to enzymatic biodegradation of the microswimmer [21] (Figure 2).